Open AccessPulsed High-Intensity Focused Ultrasound Enhances Apoptosis and Growth Inhibition of Squamous Cell Carcinoma Xenografts with Proteasome Inhibitor Bortezomib
Author(s) -
Jason A. Poff,
Clint Allen,
Bryan Traughber,
Aric Colunga,
Jianwu Xie,
Zhong Chen,
Bradford J. Wood,
Carter Van Waes,
King C. Li,
Victor Frenkel
Publication year - 2008
Publication title -
radiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.118
H-Index - 295
eISSN - 1527-1315
pISSN - 0033-8419
DOI - 10.1148/radiol.2482071674
Subject(s) - bortezomib , medicine , proteasome inhibitor , apoptosis , cd31 , urology , pathology , immunohistochemistry , multiple myeloma , biochemistry , chemistry
To investigate whether combining pulsed high-intensity focused ultrasound (HIFU) with the chemotherapeutic drug bortezomib could improve antitumor activity against murine squamous cell carcinoma (SCC) tumors.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom